Sai Balaji Andugulapati

22PUBLICATIONS
29CO-AUTHORS
MechanobiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 26, 2026
Yohimbine attenuates bleomycin-induced skin fibrosis by modulating the PI3K/Akt-MAPK signaling: an integrated network pharmacology and in vivo study.

|Aug 20, 2026
Pharmacological inhibition of CDK7 and CDK9 suppresses gastrointestinal (colon) cancer progression through modulation of stemness, epithelial-mesenchymal transition, and chemoresistance.

|Jul 14, 2026
Ligand-Engineered Cu(II) Complexes Suppress Stemness and Drug Resistance in Triple-Negative Breast Cancer.

|Jul 03, 2026
Red-Light-Triggered In Vitro and In Vivo Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

|May 26, 2026
Targeting mTOR with vistusertib attenuates metabolic steatohepatitis and prevents HCC development.

|May 15, 2026
Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti-Inflammatory Agents.

Pageof 4

Frequent Collaborators

3 joint publications

Tukki Sarkar

3 joint publications

Abhisheik Eedara

3 joint publications

Vaishnavi Kambhampati

2 joint publications

Bathini Nagendra Babu